While the potential use cases of AI have increased and its adoption has already gone up in the past few years, the pharmaceutical industry has ample headroom to leverage AI to its fullest. The reason for the lag is, although the technology is new, the methodology driving the processes is still old.
One of the major contributors toward the high cost of clinical trials is the need to perform Source Data Verification (SDV) frequently to ensure the highest quality of data. Constant checks to manage compliance processes are equally necessary and therefore resource and time intensive. With AI-driven tools, it is possible to bring down the cost without compromising on quality or accuracy.Â
AI Can Deliver Unprecedented ROI in Clinical Trials by Managing Data Quality and Compliance Print
Modified on: Mon, 8 Feb, 2021 at 1:56 PM
Did you find it helpful? Yes No
Send feedbackSorry we couldn't be helpful. Help us improve this article with your feedback.